Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine

doi:10.3748/wjg.v25.i25.3218

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7570)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

428

HTML

4408

Figures (1-5)

467

Tables (1-3)

230

Sum=5533

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

785

Download

1252

Sum=2037

Jul 7, 2019 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jul 7, 2019; 25(25): 3218-3230
Published online Jul 7, 2019. doi: 10.3748/wjg.v25.i25.3218

Full Size Figure Download Figure

Figure 1 Proton nuclear magnetic resonance spectra. A: 400 MHz representative urine proton nuclear magnetic resonance (¹H-NMR) spectra obtained from esophageal cancer (EC) patient (a) and healthy control (b); B: Tissue ¹H-NMR spectra obtained from EC tissue (c) and adjacent noncancerous tissue (d) referenced to tetradeuteriopropionate (0.0 ppm).

Citation: Liang JH, Lin Y, Ouyang T, Tang W, Huang Y, Ye W, Zhao JY, Wang ZN, Ma CC. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine. World J Gastroenterol 2019; 25(25): 3218-3230
URL: https://www.wjgnet.com/1007-9327/full/v25/i25/3218.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i25.3218